Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma survival outcomes, patterns of failure, and prognostic factors

International Journal of Gynecological Cancer

Volumn 20, Issue 3, 2010, Pages 428-433

  Teh, Jonathan ^a   Yap, Swee Peng ^a   Tham, Ivan ^b   Sethi, Vijay K ^a   Chua, Eu Jin ^a   Yeo, Richard ^a   Ho, Tew Hong ^c   Tay, Eng Hseon ^d   Chia, Yin Nin ^c   Soh, Lay Tin ^a   Khoo Tan, Hoon Seng ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^d Thomson Women Cancer Centre   (Singapore)

Author keywords

Cervical cancer; Chemoradiotherapy; Locally advanced; Prognostic factors; Survival

Indexed keywords

CISPLATIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLADDER DISEASE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTESTINE OBSTRUCTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION ENTEROPATHY; RECTOVAGINAL FISTULA; RECTUM DISEASE; RECURRENT CANCER; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT PLANNING; UROGENITAL TRACT DISEASE; UTERINE CERVIX CARCINOMA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 77952192351     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181d4a0d1     Document Type: Article

References (23)

1. Trends In Cancer Incidence In Singapore 2002-2006. Singapore Cancer Registry, Interim Report; 2008.
2. Seow A, Koh WP, Chia KS, et al. Trends in Cancer Incidence in Singapore (1968-2002). Singapore Cancer Registry, Report No. 6; 2004.
3. Barbera L, Paszat L, Thomas G, et al. The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation. Int J Radiat Oncol Biol Phys. 2006;64:1389-1394.
4. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
5. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with plevic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137-1143.
6. Peters WA, Liu PY, Barrett RGW, et al. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high risk, early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a Phase III inter group study. Presented at Soc Gynecol Oncol 30th Annual Meeting, San Fransisco, CA, February 5-9, 1999.
7. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
8. Whitney CW, Sause W, Bundy BN, et al. Randomised comparison of fluorouracil plus cisplatin versus hydroxyurea in stage IIB/IVA in carcinoma of the cervix. J Clin Oncol. 1999;17:1339-1348.
9. Lukka H, Hirte H, Fyles A, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. Clin Oncol. 2002;14:203-212.
10. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781-786.
11. Meta-Analysis Group, Medical Research Council Clinical Trials Unit, London, United Kingdom. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26:5802-5812.
12. Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K, et al. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1424-1431.
13. Patel FD, Sharma SC, Negi PS, et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys. 1994;28:335-341.
14. Hareyama M, Sakata K, Oouchi A, et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial. Cancer. 2002;94:117-124.
15. el Baradia MM, Inoue T, Inoue T, et al. High dose rate and medium dose rate brachytherapy for carcinoma of the uterine cervix: five-year clinical experience of Osaka University Hospital. J Brachyther Int. 1997;13:261-269.
16. Orton C, Seyesadr M, Somnay A, et al. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 1991;21:1425-1434.
17. Parker K, Gallop-Evans E, Hanna L, et al. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. Int J Radiat Oncol Biol Phys. 2009;74:140-146.
18. Atahan IL, Onal C, Ozyar E, et al. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer. 2007;17:833-842.
19. Novetsky AP, Einstein MH, Goldberg GL, et al. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for treatment of locally advanced cervical cancer. Gynecol Oncol. 2007;105:635-640.
20. Chen S, Liang J, Hung Y, et al. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Int J Radiat Oncol Biol Phys. 2006;66:1370-1377.
21. Pecorelli S, Zigliani L, Odicino F, et al. Revised FIGO staging for carcinoma of the cervix. Int J Gynecol Obstet. 2009;105:107-108.
22. Nag S, Erickson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201-211. (Pubitemid 30488231)
23. Nugent E, Case A, Hoff Jt, et al. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. Gynecol Oncol. 2009 Nov. 4. [Epub ahead of print].